25. Note to the cash flow statement
|
31 December |
|
|---|---|---|
(thousands of €) |
2019 |
2018 |
Adjustment for non-cash transactions |
|
|
Depreciation and amortization |
12,448 |
5,081 |
Impairment loss |
– |
1,083 |
Share-based compensation expenses |
38,297 |
26,757 |
Decrease (-)/increase in retirement benefit obligations and provisions |
(156) |
99 |
Unrealized exchange losses/gains (-) and non-cash other financial expenses |
11,169 |
(10,063) |
Discounting effect of deferred income |
6,900 |
– |
Fair value re-measurement of share subscription agreement and warrants |
181,644 |
– |
Net fair value adjustment current financial investments |
3,081 |
– |
Fair value adjustment financial assets held at fair value through profit or loss |
(5,355) |
(1,203) |
Total adjustment for non-cash transactions |
248,027 |
21,753 |
|
|
|
Adjustment for items to disclose separately under operating cash flow |
|
|
Interest expense |
1,302 |
780 |
Interest income |
(9,247) |
(5,219) |
Tax expense |
214 |
50 |
Total adjustment for items to disclose separately under operating cash flow |
(7,731) |
(4,389) |
|
|
|
Adjustment for items to disclose under investing and financing cash flows |
|
|
Gain on sale of financial assets held at fair value through profit or loss |
(2) |
(668) |
Interest income on current financial investments |
(5,059) |
– |
Total adjustment for items to disclose separately under investing and financing cash flow |
(5,061) |
(668) |
|
|
|
Change in working capital other than deferred income |
|
|
Decrease in inventories |
20 |
3 |
Increase in receivables |
(67,263) |
(76) |
Increase in liabilities |
79,940 |
19,996 |
Total change in working capital other than deferred income |
12,698 |
19,922 |